Clinical Trials Browser

Interventional × Esophageal Neoplasms × Ado-Trastuzumab Emtansine × Clear all

NCT02318901 2019-10-21

PembroMab

Phase 1/2 Terminated

16 enrolled 6 charts

BreastGastrointestinal

Breast Neoplasms, Esophageal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms